Advancement in New Drug Discovery for Treatment of Hepatitis
The current existing treatments eliminates the virus in only a little more than half of all patients. Those drugs may also have unwanted side effects which makes it difficult for patients to take them. In recent years, tremendous research advances are transforming on treatment of Hepatitis. This progress has occurred in just last three years with new and effective therapies transforming the trajectory of the disease for many patients. The scientific advances that are made by biopharmaceutical researchers have already begun to have a tangible impact on thousands of patients. In all these areas, rapid progress is being made and more new medicines are on the way. The Food and Drug Administration has approved a new drug named Harvoni, which combines sofosbuvir and ledipasvir which cures Hepatitis C virus in just eight weeks.
Related Conference of Advancement in New Drug Discovery for Treatment of Hepatitis
5th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Advancement in New Drug Discovery for Treatment of Hepatitis Conference Speakers
Recommended Sessions
- Advancement in New Drug Discovery for Treatment of Hepatitis
- Critical Care and Hepatology Nursing
- Epidemiology of Hepatitis
- Hepatitis Care
- Hepatocellular Carcinoma
- Intestinal Rehabilitation
- Liver Cancer
- Liver Diseases Diagnosis
- Liver Fibrosis
- Liver Transplantation and Surgery
- Molecular Biology of Hepatitis A, B, C, D and E Viruses
- Pancreatic Diseases
- Pathophysiology of Hepatitis
- Pediatric Gastroenterology, Hepatology and Nutrition
- Pregnancy and Liver Diseases
- Recent Advances in the Viral Hepatitis C Treatment
- Types of Hepatitis
- Viral Hepatitis Management
Related Journals
Are you interested in
- Asthma - Pulmonary Meet 2025 (France)
- Asthma and Allergy - COPD CONGRESS-2025 (Italy)
- Asthma Management - COPD SUMMIT 2025 (Italy)
- Asthma-COPD Overlap - COPD SUMMIT 2025 (Italy)
- Cardio Pulmonary Disorders - COPD CONGRESS-2025 (Italy)
- Chronic bronchitis - COPD CONGRESS-2025 (Italy)
- Chronic Bronchitis - Pulmonary Meet 2025 (France)
- Chronic obstructive pulmonary disease - COPD CONGRESS-2025 (Italy)
- Chronic Obstructive Pulmonary Disease - COPD SUMMIT 2025 (Italy)
- Clinical Immunology & Genetics - COPD SUMMIT 2025 (Italy)
- Clinical Trials - COPD SUMMIT 2025 (Italy)
- COPD - Pulmonary Meet 2025 (France)
- COPD and Air Pollution - COPD CONGRESS-2025 (Italy)
- COPD Pathogenesis - COPD CONGRESS-2025 (Italy)
- COPD Pathogenesis - COPD SUMMIT 2025 (Italy)
- COPD Preventative Measures - COPD SUMMIT 2025 (Italy)
- COPD-Chronic obstructive pulmonary disease - COPD CONGRESS-2025 (Italy)
- Cystic Fibrosis - Pulmonary Meet 2025 (France)
- Depression and Anxiety in COPD - COPD CONGRESS-2025 (Italy)
- Depression and Anxiety in COPD - COPD SUMMIT 2025 (Italy)
- Diagnosis and Treatment of COPD - COPD SUMMIT 2025 (Italy)
- Diagnosis and Treatment of COPD - COPD CONGRESS-2025 (Italy)
- Drug Discovery of COPD - COPD CONGRESS-2025 (Italy)
- Drug Discovery of COPD - COPD SUMMIT 2025 (Italy)
- Effect of COVID-19 on Lungs - COPD SUMMIT 2025 (Italy)
- Effect of COVID-19 on Lungs - COPD CONGRESS-2025 (Italy)
- Emphysema - COPD CONGRESS-2025 (Italy)
- Emphysema - Pulmonary Meet 2025 (France)
- Epidemiology - COPD SUMMIT 2025 (Italy)
- Experimental Models - COPD SUMMIT 2025 (Italy)
- Infectious Respiratory Diseases - Pulmonary Meet 2025 (France)
- Interstitial lung disease - Pulmonary Meet 2025 (France)
- Lung and COVID-19 - COPD SUMMIT 2025 (Italy)
- Lung cancer - COPD CONGRESS-2025 (Italy)
- Lung Cancer - Pulmonary Meet 2025 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - COPD CONGRESS-2025 (Italy)
- Lung problems - Pulmonary Meet 2025 (France)
- Lung transplantation - Pulmonary Meet 2025 (France)
- Lung Transplantation - COPD SUMMIT 2025 (Italy)
- Lung Transplantation - COPD CONGRESS-2025 (Italy)
- Pathophysiology & Pharmacology - COPD SUMMIT 2025 (Italy)
- Pediatric Neonatal Care in COPD - COPD CONGRESS-2025 (Italy)
- Pediatric Pulmonology & Critical care - COPD CONGRESS-2025 (Italy)
- Pharmacological and Non-Pharmacological Treatments - COPD SUMMIT 2025 (Italy)
- Pleural Diseases - Pulmonary Meet 2025 (France)
- Prevention and Control of Respiratory disease - Pulmonary Meet 2025 (France)
- Prevention of COPD - COPD CONGRESS-2025 (Italy)
- Pulmonary diseases - COPD CONGRESS-2025 (Italy)
- Pulmonary Hypertension - Pulmonary Meet 2025 (France)
- Pulmonary Rehabilitation - COPD CONGRESS-2025 (Italy)
- Pulmonary Rehabilitation - COPD SUMMIT 2025 (Italy)
- Pulmonary Rehabilitation - Pulmonary Meet 2025 (France)
- Pulmonary vascular disease - Pulmonary Meet 2025 (France)
- Pulmonology - Pulmonary Meet 2025 (France)
- Respiratory and sleep Medicine - COPD CONGRESS-2025 (Italy)
- Respiratory Disorders - Pulmonary Meet 2025 (France)
- Respiratory Failure - COPD SUMMIT 2025 (Italy)
- Respiratory Tract Infections - Pulmonary Meet 2025 (France)
- Respiratory Tract Infections - COPD CONGRESS-2025 (Italy)
- Self-Management and Prevention of COPD - COPD CONGRESS-2025 (Italy)
- Self-Management and Prevention of COPD - COPD SUMMIT 2025 (Italy)
- Sleep-Related Respiratory Disorders - Pulmonary Meet 2025 (France)
- Spirometry - COPD CONGRESS-2025 (Italy)
- Spirometry - COPD SUMMIT 2025 (Italy)
- Stages & Severity on Lung Diseases - COPD CONGRESS-2025 (Italy)
- Tobacco control - COPD CONGRESS-2025 (Italy)
- Tuberculosis - Pulmonary Meet 2025 (France)
- Types of COPD - COPD CONGRESS-2025 (Italy)